guillainbarré syndrom wikipedia guillainbarré syndrom from wikipedia free encyclopedia jump navig jump search autoimmun diseas affect peripher nervous system guillainbarré syndrom gbs other name guillainbarréstrohl syndrom landri paralysi postinfecti polyneuritis1 pronunci uk ijæ bære us ijæn bre french il bae specialti neurolog symptom muscl weak begin feet hand usual ascend upward 2 complic breath difficulti heart blood pressur problems12 usual onset rapid hour weeks2 caus unknown2 diagnost method base symptom nerv conduct studi lumbar puncture2 treatment support care intraven immunoglobulin plasmapheresi prognosi week year recovery2 frequenc 2 per 100000 peopl per year23 death 75 affected1 guillainbarré syndrom gbs rapidonset muscl weak caus immun system damag peripher nervous system2 typic side involv initi symptom chang sensat pain often back along muscl weak begin feet hand often spread arm upper body2 the symptom may develop hour weeks2 dure acut phase disord lifethreaten 15 percent peopl develop weak breath muscl therefor requir mechan ventilation1 some affect chang function autonom nervous system lead danger abnorm heart rate blood pressure2 although caus unknown under mechan involv autoimmun disord bodi immun system mistaken attack peripher nerv damag myelin insulation2 sometim immun dysfunct trigger infect less common surgeri rare vaccination12 the diagnosi usual base sign symptom exclus altern caus support test nerv conduct studi examin cerebrospin fluid2 there number subtyp base area weak result nerv conduct studi presenc certain antibodies4 it classifi acut polyneuropathy1 in sever weak prompt treatment intraven immunoglobulin plasmapheresi togeth support care lead good recoveri major people2 recoveri may take week year third perman weakness2 global death occur approxim 75 affected1 guillainbarré syndrom rare one two case per 100000 peopl everi year23 both sex part world similar rate disease12 the syndrom name french neurologist georg guillain jean alexandr barré togeth french physician andré strohl describ condit 191656 content 1 sign symptom 11 respiratori failur 12 autonom dysfunct 2 caus 3 mechan 4 diagnosi 41 spinal fluid 42 neurophysiolog 43 clinic subtyp 5 treatment 51 immunotherapi 52 respiratori failur 53 pain 54 rehabilit 6 prognosi 7 epidemiolog 8 histori 9 research direct 10 refer 11 further read 12 extern link sign symptomsedit the first symptom guillainbarré syndrom numb tingl pain alon combin this follow weak leg arm affect side equal worsen time78 the weak take half day two week reach maximum sever becom steady8 in one five peopl weak continu progress long four weeks4 the muscl neck may also affect half experi involv cranial nerv suppli head face may lead weak muscl face swallow difficulti sometim weak eye muscles4 in 8 weak affect leg paraplegia paraparesis4 involv muscl control bladder anus unusual8 in total third peopl guillainbarré syndrom continu abl walk4 onc weak stop progress persist stabl level plateau phase improv occur the plateau phase take two day six month common durat week4 painrel symptom affect half includ back pain pain tingl muscl pain pain head neck relat irrit line brain4 mani peopl guillainbarré syndrom experienc sign symptom infect 36 week prior onset neurolog symptom this may consist upper respiratori tract infect rhiniti sore throat diarrhea8 in children particular younger six year old diagnosi difficult condit often initi mistaken sometim two week caus pain difficulti walk viral infections4 bone joint problems9 on neurolog examin characterist featur reduc strength muscl reduc absent tendon reflex hypo areflexia respect howev small proport normal reflex affect limb develop areflexia may exagger reflexes4 in miller fisher variant guillainbarré syndrom see triad weak eye muscl abnorm coordin well absent reflex found8 the level conscious normal unaffect guillainbarré syndrom bickerstaff brainstem enceph subtyp may featur drowsi sleepi coma510 respiratori failureedit a quarter peopl guillainbarré syndrom develop weak breath muscl lead respiratori failur inabl breath adequ maintain healthi level oxygen andor carbon dioxid blood4811 this lifethreaten scenario complic medic problem pneumonia sever infect blood clot lung bleed digest tract 60 requir artifici ventilation8 autonom dysfunctionedit the autonom involuntari nervous system involv control bodi function heart rate blood pressur affect two third peopl guillainbarré syndrom impact variable4 twenti percent may experi sever bloodpressur fluctuat irregular heart beat sometim point heart beat stop requir pacemakerbas treatment8 other associ problem abnorm perspir chang reactiv pupils5 autonom nervous system involv affect even sever muscl weakness5 causesedit a scan electron microscopederiv imag campylobact jejuni trigger 30 case guillainbarré syndrom two third peopl guillainbarré syndrom experienc infect onset condit most common episod gastroenter respiratori tract infect in mani case exact natur infect confirmed4 approxim 30 case provok campylobact jejuni bacteria caus diarrhea a 10 attribut cytomegalovirus cmv hhv5 despit peopl campylobact cmv infect develop guillainbarré syndrom 025065 per 1000 0622 per 1000 episod respectively8 the strain campylobact involv may determin risk gbs differ form bacteria differ lipopolysaccharid surfac may induc ill see other not4 link infect gbs less certain two herpesvirus epsteinbarr virushhv4 varicella zoster virushhv3 bacterium mycoplasma pneumonia associ gbs8 the tropic viral infect dengu fever zika virus also associ episod gbs1213 previous hepat e virus infect found common peopl guillainbarré syndrome46 some case may trigger influenza virus potenti influenza vaccin an increas incid guillainbarré syndrom follow influenza immun follow 1976 swine flu outbreak h1n1 anj76 88 case per million 00088 per 1000 recipi develop complic sinc close monitor case attribut vaccin demonstr influenza induc gbs small increas incid observ subsequ vaccin campaign extent14 the 2009 flu pandem vaccin pandem swine flu virus h1n1pdm09 caus signific increas cases8 it consid benefit vaccin prevent influenza outweigh small risk gbs vaccination15 in fact natur influenza infect stronger risk factor develop gbs influenza vaccin get vaccin reduc risk gbs overal lower risk catch influenza16 even previous experienc guillainbarré syndrom consid safe receiv vaccin future4 nevertheless unit state gbs season influenza vaccin list feder govern vaccin injuri tabl 17 compens may avail nation vaccin injuri compens program18 other vaccin poliomyel tetanus measl associ risk gbs9 gbs also report associ covid19 may potenti neurolog complication192021 mechanismedit structur typic neuron neuron dendrit soma axon nucleus node ranvier axon termin schwann cell myelin sheath guillainbarré syndrom nerv damag the nerv dysfunct guillainbarré syndrom caus immun attack nerv cell peripher nervous system support structur the nerv cell bodi soma spinal cord long project axon carri electr nerv impuls neuromuscular junction impuls transfer muscl axon wrap sheath schwann cell contain myelin between schwann cell gap node ranvier axon exposed8 differ type guillainbarré syndrom featur differ type immun attack the demyelin variant aidp see featur damag myelin sheath white blood cell t lymphocyt macrophag process preced activ group blood protein known complement in contrast axon variant mediat igg antibodi complement cell membran cover axon without direct lymphocyt involvement8 various antibodi direct nerv cell report guillainbarré syndrom in axon subtyp antibodi shown bind gangliosid group substanc found peripher nerv a gangliosid molecul consist ceramid bound small group hexosetyp sugar contain various number nacetylneuramin acid group the key four gangliosid antibodi describ gm1 gd1a gt1a gq1b differ antigangliosid antibodi associ particular featur instanc gq1b antibodi link miller fisher variant gbs relat form includ bickerstaff encephalitis8 the product antibodi infect probabl result molecular mimicri immun system react microbi substanc result antibodi also react substanc occur natur body822 after campylobact infect bodi produc antibodi iga class small proport peopl also produc igg antibodi bacteri substanc cell wall substanc eg lipooligosaccharid crossreact human nerv cell gangliosid it current known process escap central toler gangliosid meant suppress product antibodi bodi substances23 not antigangliosid antibodi caus diseas recent suggest antibodi bind one type epitop simultan heterodimer bind determin respons furthermor develop pathogen antibodi may depend presenc strain bacteria bowel23 diagnosisedit the diagnosi guillainbarré syndrom depend find rapid develop muscl paralysi absent reflex absenc fever absenc like caus cerebrospin fluid analysi lumbar spinal punctur nerv conduct studi support investig common perform diagnosi gbs468 test antigangliosid antibodi often perform contribut diagnosi usual limited4 blood test general perform exclud possibl anoth caus weak low level potassium blood8 an abnorm low level sodium blood often encount guillainbarré syndrom this attribut inappropri secret antidiuret hormon lead relat retent water24 in mani case magnet reson imag spinal cord perform distinguish guillainbarré syndrom condit caus limb weak spinal cord compression48 if mri scan show enhanc nerv root may indic gbs4 in children featur present 95 scan specif guillainbarré syndrom confirm also needed9 spinal fluidedit cerebrospin fluid envelop brain spine lumbar punctur spinal tap remov small amount fluid use needl insert lumbar vertebra characterist find guillainbarré syndrom elev protein level usual greater 055 gl fewer 10 white blood cell per cubic millimet fluid albuminocytolog dissociation25 this pattern distinguish guillainbarré syndrom condit lymphoma poliomyel protein cell count elev elev csf protein level found approxim 50 patient first 3 day onset weak increas 80 first week4 repeat lumbar punctur diseas cours recommend the protein level may rise treatment administered4 neurophysiologyedit direct assess nerv conduct electr impuls exclud caus acut muscl weak well distinguish differ type guillainbarré syndrom needl electromyographi emg nerv conduct studi may perform in first two week investig may show abnormality415 neurophysiolog studi requir diagnosis8 formal criteria exist main subtyp guillainbarré syndrom aidp amanamsan see may misclassifi case particular revers conduct failur therefor chang criteria proposed26 sometim repeat test may helpful26 clinic subtypesedit a number subtyp guillainbarré syndrom recognized426 despit mani peopl overlap symptom make classif difficult individu cases527 all type partial form for instanc peopl experi isol eyemov coordin problem thought subtyp miller fisher syndrom similar antigangliosid antibodi patterns1027 type4 symptom popul affect nerv conduct studi antigangliosid antibodi acut inflammatori demyelin polyneuropathi aidp sensori symptom muscl weak often cranial nerv weak autonom involv most common europ north america demyelin polyneuropathi no clear associ acut motor axon neuropathi aman isol muscl weak without sensori symptom less 10 cranial nerv involv uncommon rare europ north america substanti proport 3065 asia central south america sometim call chines paralyt syndrom axon polyneuropathi normal sensori action potenti gm1ab gd1a galnacgd1a acut motor sensori axon neuropathi amsan sever muscl weak similar aman sensori loss axon polyneuropathi reduc absent sensori action potenti gm1 gd1a pharyngealcervicalbrachi variant weak particular throat muscl face neck shoulder muscl general normal sometim axon neuropathi arm most gt1a occasion gq1b rare gd1a miller fisher syndrom ataxia eye muscl weak areflexia usual limb weak this variant occur common men women 21 ratio case typic occur spring averag age occurr 43 year old28 general normal sometim discret chang sensori conduct hreflex detect gq1b gt1a other diagnost entiti often includ spectrum guillainbarré syndrom bickerstaff brainstem enceph bbe instanc part group condit regard form miller fisher syndrom antigq1b antibodi syndrome10 well relat condit label acut atax hypersomnol coordin problem drowsi present muscl weak detected27 bbe character rapid onset ophthalmoplegia ataxia disturb conscious may associ absent decreas tendon reflex well babinski sign27 the cours diseas usual monophas recurr episod report mri abnorm brainstem report 1110 whether isol acut sensori loss regard form guillainbarré syndrom matter disput rare occurr compar gbs muscl weak sensori symptoms15 treatmentedit immunotherapyedit plasmapheresi intraven immunoglobulin ivig two main immunotherapi treatment gbs plasmapheresi attempt reduc bodi attack nervous system filter antibodi bloodstream similar administr ivig neutral harm antibodi inflamm these two treatment equal effect combin two signific better either alone29 plasmapheresi speed recoveri use within four week onset symptoms30 ivig work well plasmapheresi start within two week onset symptom fewer complications30 ivig usual use first eas administr safeti it use without risk occasion caus liver inflamm rare case kidney failure31 glucocorticoid alon found effect speed recoveri could potenti delay recovery32 respiratori failureedit respiratori failur may requir intub trachea breath support mechan ventil general intens care unit the need ventilatori support anticip measur two spirometrybas breath test forc vital capac fvc negat inspiratori forc nif an fvc less 15 ml per kilogram bodi weight nif less 60 cmh2o consid marker sever respiratori failure33 painedit while pain common peopl guillainbarré syndrom studi compar differ type pain medic insuffici make recommend used34 rehabilitationedit follow acut phase around 40 peopl requir intens rehabilit help multidisciplinari team focus improv activ daili live adls35 studi subject limit like intens rehabilit improv longterm symptoms36 team may includ physic therapist occup therapist speech languag pathologist social worker psychologist alli health profession nurs the team usual work supervis neurologist rehabilit physician direct treatment goals35 physiotherapi intervent includ strength endur gait train graduat increas mobil mainten postur align well joint function occup therapi aim improv everyday function domest communiti task well drive work home modif gait aid orthot splint may provided35 speechlanguag patholog input may requir speech swallow problem well support communic requir ongo breath support often tracheostomi nutrit support may provid team dietitian psychologist may provid counsel support psycholog intervent may also requir anxieti fear depression35 prognosisedit guillainbarré syndrom lead death result number complic sever infect blood clot cardiac arrest like due autonom neuropathi despit optimum care occur 5 cases8 there variat rate extent recovery8 the prognosi guillainbarré syndrom determin main age 40 may poorer outcom sever symptom two week furthermor experienc diarrhea onset diseas wors prognosis11 on nerv conduct studi presenc conduct block predict poorer outcom 6 months11 in receiv intraven immunoglobulin smaller increas igg blood two week administr associ poorer mobil outcom six month whose igg level increas substantially11 if diseas continu progress beyond four week multipl fluctuat sever two eight week diagnosi may chronic inflammatori demyelin polyneuropathi treat differently4 in research studi outcom episod guillainbarré syndrom record scale 0 6 0 denot complet healthi 1 minor symptom abl run 2 abl walk run 3 requir stick support 4 confin bed chair 5 requir longterm respiratori support 6 death37 the healthrel qualiti life hrql attack guillainbarré syndrom signific impair about fifth unabl walk unaid six month mani experi chronic pain fatigu difficulti work educ hobbi social activities38 hrql improv signific first year38 epidemiologyedit see also list peopl guillainbarré syndrom in western countri number new episod per year estim 089 189 case per 100000 peopl children young adult less like affect elder risk increas 20 everi decad life3 men like develop guillainbarré syndrom women relat risk men 178 compar women38 the distribut subtyp vari countri in europ unit state 6080 peopl guillainbarré syndrom demyelin subtyp aidp aman affect small number 67 in asia central south america proport signific higher 3065 this may relat exposur differ kind infect also genet characterist population4 miller fisher variant thought common southeast asia810 historyedit georg guillain togeth barré strohl describ two case selflimit acut paralysi peculiar chang cerebrospin fluid he succeed teacher pierr mari professor neurolog salpêtrièr hospit pari 192539 french physician jeanbaptist octav landri first describ disord 185940 in 1916 georg guillain jean alexandr barré andré strohl diagnos two soldier ill describ key diagnost abnormalityalbuminocytolog dissociationof increas spinal fluid protein concentr normal cell count5641 canadian neurologist c miller fisher describ variant bear name 19561042 british neurologist edwin bickerstaff base birmingham describ brainstem enceph type 1951 philip cloak made contribut anoth paper 1957104344 guillain report featur full descript 193810 further subtyp describ sinc form featur pure ataxia type caus pharyngealcervicalbrachi weakness10 the axon subtyp first describ 198645 diagnost criteria develop late 1970s seri case associ swine flu vaccin these refin 1990446 the case definit revis brighton collabor vaccin safeti 200947 main intend research4 plasma exchang first use 1978 benefit confirm larger studi 198548 intraven immunoglobulin introduc 1988 studi earli 1990s demonstr less effect plasma exchange48 research directionsedit the understand diseas mechan guillainbarré syndrom evolv recent years15 develop new treatment limit sinc immunotherapi introduc 1980s 1990s1548 current research aim demonstr whether peopl receiv ivig might benefit second cours antibodi level measur blood treatment shown small increase1148 studi immunosuppress drug mycophenol mofetil brainderiv neurotroph factor interferon beta ifn demonstr benefit support widespread use48 an anim model experiment autoimmun neuriti rat often use studi agent shown promis glatiram acet quinpramin fasudil inhibitor rhokinas enzyme15 heart drug flecainide48 an antibodi target antigd3 antigangliosid antibodi shown benefit laboratori research15 given role complement system gbs suggest complement inhibitor drug eculizumab may effective48 referencesedit b c e f g h ferri ff 2016 ferri clinic advisor 2017 5 book 1 elsevi health scienc p 529 isbn 9780323448383 archiv origin 20160821 b c e f g h j k l n p q r guillainbarré syndrom fact sheet niam june 1 2016 archiv origin 5 august 2016 retriev 13 august 2016 b c sejvar jj baughman al wise m morgan ow 2011 popul incid guillainbarré syndrom systemat review metaanalysi neuroepidemiolog 36 2 12333 doi101159000324710 pmc 5703046 pmid 21422765 b c e f g h j k l n p q r u v w x z aa ab van den berg b walgaard c drenthen j fokk c jacob bc van doorn pa august 2014 guillainbarré syndrom pathogenesi diagnosi treatment prognosi natur review neurolog 10 8 46982 doi101038nrneurol2014121 pmid 25023340 s2cid 25154778 b c e f van doorn pa rut l jacob bc octob 2008 clinic featur pathogenesi treatment guillainbarré syndrom the lancet neurolog 7 10 93950 doi101016s1474442208702151 pmid 18848313 s2cid 9307245 b c eldar ah chapman j april 2014 guillain barré syndrom immun mediat neuropathi diagnosi classif autoimmun review 13 45 52530 doi101016jautrev201401033 pmid 24434363 willison hj jacob bc van doorn pa august 2016 guillainbarré syndrom lancet 388 10045 71727 doi101016s0140673616003391 pmid 26948435 b c e f g h j k l n p q r u v w yuki n hartung hp june 2012 guillainbarré syndrom the new england journal medicin 366 24 2294304 doi101056nejmra1114525 pmid 22694000 b c ryan mm decemb 2013 pediatr guillainbarré syndrom current opinion pediatr 25 6 68993 doi101097mop0b013e328365ad3f pmid 24240288 s2cid 34011924 b c e f g h shahrizaila n yuki n may 2013 bickerstaff brainstem enceph fisher syndrom antigq1b antibodi syndrom journal neurolog neurosurgeri psychiatri 84 5 57683 doi101136jnnp2012302824 pmid 22984203 b c e van doorn pa kuitwaard k walgaard c van koningsveld r rut l jacob bc may 2010 ivig treatment prognosi guillainbarré syndrom journal clinic immunolog 30 suppl 1 s748 doi101007s1087501094074 pmc 2883091 pmid 20396937 carodart fj wichmann o farrar j gascón j septemb 2013 neurolog complic dengu virus infect the lancet neurolog 12 9 906919 doi101016s1474442213701509 pmid 23948177 s2cid 13948773 gather d kohl a februari 2016 zika virus previous slow pandem spread rapid america pdf the journal general virolog 97 2 269273 doi101099jgv0000381 pmid 26684466 lehmann hc hartung hp kieseier bc hugh ra septemb 2010 guillainbarré syndrom exposur influenza virus the lancet infecti diseas 10 9 64351 doi101016s1473309910701407 pmid 20797646 b c e f g rinaldi s june 2013 updat guillainbarré syndrom journal peripher nervous system 18 2 99112 doi101111jns512020 pmid 23781958 destefano f bodenstab hm offit pa august 2019 princip controversi vaccin safeti unit state clinic infecti diseas 69 4 726731 doi101093cidciz135 pmid 30753348 vaccin injuri tabl hrsa pdf hrsa march 22 2017 retriev octob 23 2019 nation vaccin injuri compens program wwwhrsagov 11 may 2017 retriev 24 octob 2019 ellul ma benjamin l singh b lant s michael bd easton a et al septemb 2020 neurolog associ covid19 the lancet neurolog 19 9 767783 doi101016s1474442220302210 pmid 32622375 toscano g palmerini f ravaglia s ruiz l invernizzi p cuzzoni mg et al june 2020 guillainbarré syndrom associ sarscov2 the new england journal medicin 382 26 25742576 doi101056nejmc2009191 pmc 7182017 pmid 32302082 paterson rw brown rl benjamin l nortley r wiethoff s bharucha t et al juli 2020 the emerg spectrum covid19 neurolog clinic radiolog laboratori find brain doi101093brainawaa240 pmid 32637987 kuwabara s yuki n decemb 2013 axon guillainbarré syndrom concept controversi the lancet neurolog 12 12 11808 doi101016s1474442213702151 pmid 24229616 s2cid 35101547 b willison hj goodyear cs septemb 2013 glycolipid antigen autoantibodi autoimmun neuropathi trend immunolog 34 9 4539 doi101016jit201305001 pmid 23770405 spasovski g vanhold r allolio b annan d ball s bichet d et al march 2014 clinic practic guidelin diagnosi treatment hyponatraemia european journal endocrinolog 170 3 g147 doi101530eje131020 pmid 24569125 ropper ah april 1992 the guillainbarré syndrom the new england journal medicin 326 17 11306 doi101056nejm199204233261706 pmid 1552914 b c uncini a kuwabara s august 2012 electrodiagnost criteria guillainbarrè syndrom critic revis need updat clinic neurophysiolog 123 8 148795 doi101016jclinph201201025 pmid 22480600 s2cid 33276521 b c wakerley br uncini a yuki n septemb 2014 guillainbarré miller fisher syndromesnew diagnost classif natur review neurolog 10 9 53744 doi101038nrneurol2014138 pmid 25072194 s2cid 205515884 mori m kuwabara s yuki n januari 2012 fisher syndrom clinic featur immunopathogenesi manag expert review neurotherapeut 12 1 3951 doi101586ern11182 pmid 22149656 s2cid 5597853 hugh ra swan av van doorn pa septemb 2014 intraven immunoglobulin guillainbarré syndrom the cochran databas systemat review 9 9 cd002063 doi10100214651858cd002063pub6 pmc 6781841 pmid 25238327 b hugh ra wijdick ef barohn r benson e cornblath dr hahn af et al septemb 2003 practic paramet immunotherapi guillainbarré syndrom report qualiti standard subcommitte american academi neurolog neurolog 61 6 73640 doi101212wnl616736 pmid 14504313 dantal j octob 2013 intraven immunoglobulin indepth review excipi acut kidney injuri risk american journal nephrolog 38 4 27584 doi101159000354893 pmid 24051350 hugh richard ac brassington ruth gunn angela a van doorn pieter a 20161024 corticosteroid guillainbarré syndrom the cochran databas systemat review 10 cd001446 doi10100214651858cd001446pub5 issn 1469493x pmc 6464149 pmid 27775812 dimachki mm barohn rj may 2013 guillainbarré syndrom variant neurolog clinic 31 2 491510 doi101016jncl201301005 pmc 3939842 pmid 23642721 liu jia wang lune mcnicol ewan d 20150409 pharmacolog treatment pain guillainbarré syndrom the cochran databas systemat review 4 cd009950 doi10100214651858cd009950pub3 issn 1469493x pmc 6361619 pmid 25855461 b c khan f amatya b septemb 2012 rehabilit intervent patient acut demyelin inflammatori polyneuropathi systemat review european journal physic rehabilit medicin 48 3 50722 pmid 22820829 archiv origin 20150826 khan f ng l amatya b brand c turnerstok l octob 2010 multidisciplinari care guillainbarré syndrom the cochran databas systemat review 10 cd008505 doi10100214651858cd008505pub2 pmid 20927774 hugh ra swan av raphaël jc annan d van koningsveld r van doorn pa septemb 2007 immunotherapi guillainbarré syndrom systemat review brain 130 pt 9 224557 doi101093brainawm004 pmid 17337484 archiv origin 20141029 b darweesh sk polind s mulder mj baena cp van leeuwen n franco oh et al march 2014 healthrel qualiti life guillainbarré syndrom patient systemat review journal peripher nervous system 19 1 2435 doi101111jns512051 pmid 24456426 goetz cg may 1998 georg guillain neurolog explor america neurolog 50 5 14515 doi101212wnl5051451 pmid 9596004 s2cid 823333 landri j 1859 note sur la paralysi ascendant aiguë gazett hebdomadair de médecin et de chirurgi 6 472474 486488 archiv origin 20170227 guillain g barré j strohl a 1916 sur un syndrom de radiculonévrit avec hyperalbuminos du liquid céphalorachidien san réaction cellulair remarqu sur les caractèr cliniqu et graphiqu des réflex tendineux bulletin et mémoir de la société des médecin des hôpitaux de pari 40 146270 fisher m juli 1956 an unusu variant acut idiopath polyneur syndrom ophthalmoplegia ataxia areflexia the new england journal medicin 255 2 5765 doi101056nejm195607122550201 pmid 13334797 bickerstaff er cloak pc juli 1951 mesenceph rhombenceph british medic journal 2 4723 7781 doi101136bmj2472377 pmc 2069534 pmid 14848512 bickerstaff er june 1957 brainstem enceph observ grave syndrom benign prognosi british medic journal 1 5032 13847 doi101136bmj150321384 pmc 1973653 pmid 13436795 compston a 20160701 recurr chronic relaps guillainbarré polyneur pk thoma rg lascell jf hallpik rl hewer from institut neurolog nation hospit queen squar royal nation orthopaed hospit guy hospit london brain 1969 92 589606 an acut axon form guillainbarré polyneuropathi te feasbi jj gilbert wf brown cf bolton af hahn wf koopman dw zochodn brain 1986 109 11151126 brain 139 7 20962100 doi101093brainaww127 issn 00068950 asburi ak cornblath dr 1990 assess current diagnost criteria guillainbarré syndrom annal neurolog 27 suppl s214 doi101002ana410270707 pmid 2194422 sejvar jj kohl ks gidudu j amato a bakshi n baxter r et al januari 2011 guillainbarré syndrom fisher syndrom case definit guidelin collect analysi present immun safeti data vaccin 29 3 599612 doi101016jvaccine201006003 pmid 20600491 b c e f g walgaard c jacob bc van doorn pa march 2011 emerg drug guillainbarré syndrom expert opinion emerg drug 16 1 10520 doi101517147282142011531699 pmid 21352072 s2cid 3162151 further readingedit steinberg gj parri js 2006 guillainbarré syndrom diagnosi recoveri new york ny demo ann press american academi neurolog isbn 9781932603569 extern linksedit guillainbarré syndrom curli classif d icd10 g610 icd9cm 3570 omim 139393 mesh d020275 diseasesdb 5465 extern resourc medlineplus 000684 emedicin emerg222 neuro7 pmr48 neuro598 patient uk guillainbarré syndrom scholia q205214 v e diseas relat peripher nervous system mononeuropathi arm median nerv carpal tunnel syndrom ape hand deform ulnar nerv ulnar nerv entrap froment sign ulnar tunnel syndrom ulnar claw radial nerv radial neuropathi wrist drop cheiralgia paresthetica long thorac nerv wing scapula backpack palsi leg later cutan nerv thigh meralgia paraesthetica tibial nerv tarsal tunnel syndrom plantar nerv morton neuroma superior gluteal nerv trendelenburg sign sciatic nerv piriformi syndrom cranial nerv see templatecrani nerv diseas polyneuropathi polyradiculoneuropathi hmsn charcotmarietooth diseas dejerinesotta diseas refsum diseas hereditari spastic paraplegia hereditari neuropathi liabil pressur palsi famili amyloid neuropathi autoimmun demyelin diseas guillainbarré syndrom chronic inflammatori demyelin polyneuropathi radiculopathi plexopathi brachial plexus injuri thorac outlet syndrom phantom limb other alcohol polyneuropathi other general complex region pain syndrom mononeur multiplex peripher neuropathi neuralgia nerv compress syndrom v e hypersensit autoimmun diseas type iallergyatopi ige foreign atop eczema allerg urticaria allerg rhiniti hay fever allerg asthma anaphylaxi food allergi common allergi includ milk egg peanut tree nut seafood soy wheat penicillin allergi autoimmun eosinophil esophag type iiadcc igm igg foreign hemolyt diseas newborn autoimmun cytotox autoimmun hemolyt anemia immun thrombocytopen purpura bullous pemphigoid pemphigus vulgari rheumat fever goodpastur syndrom guillainbarré syndrom type vreceptor grave diseas myasthenia gravi pernici anemia type iii immun complex foreign henochschönlein purpura hypersensit vascul reactiv arthriti farmer lung poststreptococc glomerulonephr serum sick arthus reaction autoimmun system lupus erythematosus subacut bacteri endocard rheumatoid arthriti type ivcellmedi t cell foreign allerg contact dermat mantoux test autoimmun diabet mellitus type 1 hashimoto thyroid multipl sclerosi coeliac diseas giantcel arter postorgasm ill syndrom reactiv arthriti gvhd transfusionassoci graft versus host diseas unknown multipl foreign hypersensit pneumon allerg bronchopulmonari aspergillosi transplant reject latex allergi i iv autoimmun sjögren syndrom autoimmun hepat autoimmun polyendocrin syndrom aps1 aps2 autoimmun adren system autoimmun diseas retriev httpsenwikipediaorgwindexphptitl guillainbarrésyndromeoldid 991009963 categori autoimmun diseas cytomegalovirusassoci diseas medic triad peripher nervous system disord syndrom affect nervous system hidden categori cs1 long volum valu articl short descript short descript differ wikidata good articl articl curli link wikipedia medicin articl readi translat rttneuro navig menu person tool not log talk contribut creat account log namespac articl talk variant view read edit view histori more search navig main page content current event random articl about wikipedia contact us donat contribut help learn edit communiti portal recent chang upload file tool what link relat chang upload file special page perman link page inform cite page wikidata item printexport download pdf printabl version in project wikimedia common languag asturianu azrbaycanca català etina dansk deutsch español esperanto françai gaeilg hrvatski bahasa indonesia interlingua italiano lëtzebuergesch lingua franca nova magyar bahasa melayu nederland norsk bokmål norsk nynorsk piemontèi polski portuguê român simpl english slovenina slovenina srpski srpskohrvatski suomi svenska türkçe ting vit edit link this page last edit 27 novemb 2020 1959 utc text avail creativ common attributionsharealik licens addit term may appli by use site agre term use privaci polici wikipedia regist trademark wikimedia foundat inc nonprofit organ privaci polici about wikipedia disclaim contact wikipedia mobil view develop statist cooki statement
